Treatment results of post-operative radiotherapy in patients with salivary duct carcinoma of the major salivary glands

British Journal of Radiology

Volumn 85, Issue 1018, 2012, Pages

  Kim, J Y ^a   Lee, Sang Wook ^b   Cho, K J ^c   Kim, S Y ^c   Nam, S Y ^c   Choi, S H ^c   Roh, J L ^c   Choi, E K ^b   Kim, J H ^b   Song, S Y ^b   Shin, H S ^a   Chang, S K ^a   Ahn, S D ^b  

^a CHA University   (South Korea)

^b University of Ulsan   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER LOCALIZATION; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CERVICAL LYMPH NODE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE DURATION; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DISTANT METASTASIS FREE SURVIVAL; FACE PAIN; FACIAL NERVE DISEASE; FEMALE; HUMAN; LYMPH VESSEL METASTASIS; MALE; MOUTH ULCER; NECK DISSECTION; NECK PAIN; OVERALL SURVIVAL; PAROTID GLAND CARCINOMA; PAROTIDECTOMY; POSTOPERATIVE CARE; PRIMARY TUMOR; RETROSPECTIVE STUDY; SALIVARY GLAND CANCER; SALIVARY GLAND CARCINOMA; SALIVARY GLAND DISEASE; SALIVARY GLAND DUCT CARCINOMA; TREATMENT FAILURE; TUMOR VOLUME;

ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE CARE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SALIVARY GLAND NEOPLASMS; TREATMENT OUTCOME;

EID: 84866864278     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/21574486     Document Type: Article

References (24)

1. Kleinsasser O, Klein HJ, Hubner G. Salivary duct carcinoma. A group of salivary gland tumors analogous to mammary duct carcinoma. [In German.] Arch Klin Exp Ohren Nasen Kehlkopfheilkd 1968;192:100-5.
2. Colmenero Ruiz C, Patrón Romero M, Martín Pérez M. Salivary duct carcinoma: a report of nine cases. J Oral Maxillofac Surg 1993;51:641-6.
3. Jaehne M, Roeser K, Jaekel T, Schepers JD, Albert N, Loning T. Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases. Cancer 2005;103:2526-33. (Pubitemid 40800531)
4. Gal R, Strauss M, Zohar Y, Kessler E. Salivary duct carcinoma of the parotid gland. Cytologic and histopathologic study. Acta Cytol 1985;29:454-6. (Pubitemid 15044842)
5. Hosal AS, Fan C, Barnes L, Myers EN. Salivary duct carcinoma. Otolaryngol Head Neck Surg 2003;129:720-5. (Pubitemid 37509773)
6. Delgado R, Vuitch F, Albores-Saavedra J. Salivary duct carcinoma. Cancer 1993;72:1503-12. (Pubitemid 23249270)
7. Guzzo M, Di Palma S, Grandi C, Molinari R. Salivary duct carcinoma: clinical characteristics and treatment strategies. Head Neck 1997;19:126-33. (Pubitemid 27108063)
8. Kane WJ, McCaffrey TV, Olsen KD, Lewis JE. Primary parotid malignancies. A clinical and pathologic review. Arch Otolaryngol Head Neck Surg 1991;117:307-15.
9. Luna MA, Batsakis JG, Ordonez NG, Mackay B, Tortoledo ME. Salivary gland adenocarcinomas: a clinicopathologic analysis of three distinctive types. Semin Diagn Pathol 1987;4:117-35.
10. Grenko RT, Gemryd P, Tytor M, Lundqvist PG, Boeryd B. Salivary duct carcinoma. Histopathology 1995;26:261-6.
11. Lewis JE, McKinney BC, Weiland LH, Ferreiro JA, Olsen KD. Salivary duct carcinoma. Clinicopathologic and immunohistochemical review of 26 cases. Cancer 1996;77:223-30. (Pubitemid 26023338)
12. Brandwein MS, Jagirdar J, Patil J, Biller H, Kaneko M. Salivary duct carcinoma (cribriform salivary carcinoma of excretory ducts). A clinicopathologic and immunohistochemical study of 12 cases. Cancer 1990;65:2307-14. (Pubitemid 20164840)
13. Roh JL, Cho KJ, Kwon GY, Choi SH, Nam SY, Kim SY. Prognostic values of pathologic findings and hypoxia markers in 21 patients with salivary duct carcinoma. J Surg Oncol 2008;97:596-600.
14. Ko YH, Roh JH, Son YI, Chung MK, Jang JY, Byun H, et al. Expression of mitotic checkpoint proteins BUB1B and MAD2L1 in salivary duct carcinomas. J Oral Pathol Med 2010;39:349-55.
15. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, et al. AJCC Cancer Staging Manual. 6th edn. New York, NY: Springer-Verlag; 2002.
16. Afzelius LE, Cameron WR, Svensson C. Salivary duct carcinoma-a clinicopathologic study of 12 cases. Head Neck Surg 1987;9:151-6.
17. Barnes L, Rao U, Krause J, Contis L, Schwartz A, Scalamogna P. Salivary duct carcinoma. Part I. A clinicopathologic evaluation and DNA image analysis of 13 cases with review of the literature. Oral Surg Oral Med Oral Pathol 1994;78:64-73.
18. Dimery IW, Legha SS, Shirinian M, Hong WK. Fluorouracil, doxorubicin, cyclophosphamide, and cisplatin combination chemotherapy in advanced or recurrent salivary gland carcinoma. J Clin Oncol 1990;8:1056-62. (Pubitemid 20200194)
19. Dodd RL, Slevin NJ. Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies. Oral Oncol 2006;42:759-69. (Pubitemid 44307768)
20. Nabili V, Tan JW, Bhuta S, Sercarz JA, Head CS. Salivary duct carcinoma: a clinical and histologic review with implications for trastuzumab therapy. Head Neck 2007;29: 907-12.
21. Nashed M, Casasola RJ. Biological therapy of salivary duct carcinoma. J Laryngol Otol 2009;123:250-2.
22. Luna MA, Ordonez NG, Mackay B, Batsakis JG, Guillamondegui O. Salivary epithelial-myoepithelial carcinomas of intercalated ducts: a clinical, electron microscopic, and immunocytochemical study. Oral Surg Oral Med Oral Pathol 1985;59:482-90. (Pubitemid 15000191)
23. Barnes L, Rao U, Contis L, Krause J, Schwartz A, Scalamogna P. Salivary duct carcinoma. Part II. Immunohistochemical evaluation of 13 cases for estrogen and progesterone receptors, cathepsin D, and c-erbB-2 protein. Oral Surg Oral Med Oral Pathol 1994;78:74-80.
24. Van der Auwera I, Cao Y, Tille JC, Pepper MS, Jackson DG, Fox SB, et al. First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours. Br J Cancer 2006;95:1611-25. (Pubitemid 44950785)